Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (4983)	12/3/1997 2:40:00 PM
From: aknahow	Read Replies (3) \| Respond to of 17367

Andy, yes but that would mean taking all post as true and that is something I know is not true.<g> Opalapril could have said something about the name a long time ago, but remained silent. The added detail about an Opal at Xoma does not ring true. It is possible and even perhaps probable that someone e-mailed grandfather Lapril and suggested the Opal post. Anyone can be Opal and only a few Opa. Which is more interesting in the absence of news from XOMA? Looking at past history of Xoma ifno releases if we do not hear about the liver trials, or a deal the next release could come as late as March re yr. end results. That's worse than not knowing if the Opal post is genuine.